Peripheral neuropathic pain -: a multidimensional burden for patients

被引:169
|
作者
Meyer-Rosberg, K
Kvarnström, A
Kinnman, E
Gordh, T
Nordfors, LO
Kristofferson, A
机构
[1] Astra Pain Control AB, SE-15185 Sodertalje, Sweden
[2] Univ Uppsala Hosp, Dept Anesthesiol & Intens Care, Acad Hosp, SE-75105 Uppsala, Sweden
[3] Danderyd Hosp, Dept Anesthesiol & Intens Care, SE-18288 Stockholm, Sweden
关键词
peripheral neuropathic pain; peripheral nerve injury; nerve root lesion; SF-36; Nottingham Health Profile; health related quality of life; rating scale;
D O I
10.1053/eujp.2001.0259
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
The present study was undertaken to assess the health-related quality of life (HRQoL) and burden of illness due to pain and its treatment for patients with peripheral neuropathic pain (PNP). It is the first step in finding reliable instruments/targets to evaluate treatment outcome in this patient population. Study population consisted of 126 patients suffering from neuropathic, pain due to a peripheral nerve or root lesion, recruited from two multidisciplinary pain clinics. HRQoL was examined using Short Form 36 (SF-36) Health Survey and Nottingham Health Profile (NHP). Pain intensity in four categories (at rest and evoked by movement, touch and cold) was rated on a visual analogue scale (VAS). Degree of discomfort from pain and 25 symptoms related to pain and side-effects was also assessed. Reduction in workload due to pain was recorded, as was the pain relief from previous and current treatments and the reasons for discontinuing previous treatments. All dimensions in SF-36 and NHP were significantly impaired. SF-36 was a valid instrument for describing the impact of pain on the HRQoL of patients with PNP. NHP had a lower reliability but has other advantages that might be of importance. Many patients experienced poor pain relief from ongoing pain treatments. Most previous treatments were discontinued owing to lack of efficacy and/or severe side-effects. Many patients experienced a high intensity of at least one type of pain; median VAS for the highest pain intensity score of each patient (any type of pain) was 74/100. Besides pain, patients were most bothered by difficulty in sleeping, lack of energy, drowsiness, difficulty in concentrating and dry mouth. Employment status was reduced owing to pain in 52% of the patients. The intense pain, other troublesome symptoms, limited efficacy and tolerability of available treatments, together with the impaired health and reduced work status, amount to a substantial burden for patients with PNP. (C) 2001 European Federation of Chapters of the International Association for the Study of Pain.
引用
收藏
页码:379 / 389
页数:11
相关论文
共 50 条
  • [21] Peripheral nerve stimulation for neuropathic pain
    Slavin, Konstantin V.
    NEUROTHERAPEUTICS, 2008, 5 (01) : 100 - 106
  • [22] Neuropathic pain in hereditary peripheral neuropathy
    Jeong, Na Young
    Shin, Youn Ho
    Jung, Junyang
    JOURNAL OF EXERCISE REHABILITATION, 2013, 9 (04) : 397 - 399
  • [23] Neuropathic pain: Peripheral and central mechanisms
    Jensen, Troels Staehelin
    Finnerup, Nanna Brix
    ACUTE AND CHRONIC PAIN: WHERE WE ARE AND WHERE WE HAVE TO GO, 2009, : 33 - +
  • [24] Pain severity and the economic burden of neuropathic pain in the United States: BEAT Neuropathic Pain Observational Study
    Schaefer, Caroline
    Sadosky, Alesia
    Mann, Rachael
    Daniel, Shoshana
    Parsons, Bruce
    Tuchman, Michael
    Anschel, Alan
    Stacey, Brett R.
    Nalamachu, Srinivas
    Nieshoff, Edward
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2014, 6 : 483 - 496
  • [25] PATIENTS WITH CENTRAL AND PERIPHERAL NEUROPATHIC PAIN: EVALUATION OF NEUROPATHIC PAIN THROUGH PAIN SCALES, SPECIFIC NEUROPHYSIOLOGICAL REFLEX TECHNIQUES AND CLINICAL EVALUATION
    Selcuki, D.
    Dogan, N.
    Kisabay, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2015, 20 (02) : 229 - 229
  • [26] Management of peripheral neuropathic pain: An overview
    Vatine, JJ
    Faran, S
    Lerman, Y
    ADVANCES IN PHYSICAL AND REHABILITATION MEDICINE, 2003, : 155 - 162
  • [27] Mechanisms and management of peripheral neuropathic pain
    Sindrup, Soren H.
    NEUROMUSCULAR DISORDERS, 2006, 16 : S190 - S190
  • [28] Peripheral actions of cytokines in neuropathic pain
    Sommer, CL
    FASEB JOURNAL, 2004, 18 (04): : A18 - A18
  • [29] Chemotherapy induced peripheral neuropathic pain
    Park, Hue Jung
    KOREAN JOURNAL OF ANESTHESIOLOGY, 2014, 67 (01) : 4 - 7
  • [30] DISEASE BURDEN AND PAIN IN OBESE CANCER PATIENTS WITH CHEMOTHERAPY INDUCED NEUROPATHIC PAIN: OPPORTUNITY FOR INTERVENTION
    Martin, Emily C.
    Trahan, Lisa H.
    Cox, Matthew
    Novy, Diane
    Dougherty, Patrick M.
    ANNALS OF BEHAVIORAL MEDICINE, 2016, 50 : S186 - S186